News
Nexavar (sorafenib) is a brand-name drug that’s ... Keep reading for specific information about the dosage of Nexavar, including its strength and how to take the medication.
Discover comprehensive details about Sorafenib, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
The primary end point was overall survival (OS) of patients who were prescribed standard starting dosage sorafenib (800 mg/d per os) versus that of patients who were prescribed reduced starting dose ...
The combination therapy can be used as first-line treatment for unresectable or metastatic forms of the cancer ... ipilimumab compared with either sorafenib or lenvatinib, which are standards ...
Aim To investigate the role of sorafenib dosage escalation in Asian patients with metastatic renal cell carcinoma that had progressed after routine dosages. Patients & methods Sorafenib dosage ...
Desmoid tumors (also referred to as aggressive fibromatosis) are connective tissue neoplasms that can arise in any anatomical location and infiltrate the mesentery, neurovascular structures, and ...
Although single-agent sorafenib has an effect on HCC, its adverse effects, such as rash, diarrhea, high blood pressure, and hand-foot syndrome, limit high-dosage use of sorafenib 14. Therefore ...
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer By Lori Solomon HealthDay Reporter TUESDAY, April 15, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...
Patients self-administered sunitinib orally at a starting dosage of 37.5 mg once daily in the morning; 12.5 mg incremental dose reductions were permitted to manage toxicities. Sorafenib 400 mg twice ...
A total of 41 patients (33 male and eight female; median age 53 years) who had progressed on routine dosages of sorafenib and met the inclusion criteria entered the trial and underwent a dosage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results